CA2151961A1 - Peptides acycliques analogues du peptide natriuretique atrial; methode de preparation et utilisation - Google Patents

Peptides acycliques analogues du peptide natriuretique atrial; methode de preparation et utilisation

Info

Publication number
CA2151961A1
CA2151961A1 CA002151961A CA2151961A CA2151961A1 CA 2151961 A1 CA2151961 A1 CA 2151961A1 CA 002151961 A CA002151961 A CA 002151961A CA 2151961 A CA2151961 A CA 2151961A CA 2151961 A1 CA2151961 A1 CA 2151961A1
Authority
CA
Canada
Prior art keywords
denotes
carbon atoms
different
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002151961A
Other languages
English (en)
Inventor
Klaus-Peter Voges
Rolf Henning
Walter Hubsch
Jan-Bernd Lenfers
Martin Beuck
Gudrun Theiss
Johannes-Peter Stasch
Claudia Hirth-Dietrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2151961A1 publication Critical patent/CA2151961A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002151961A 1992-12-18 1993-12-06 Peptides acycliques analogues du peptide natriuretique atrial; methode de preparation et utilisation Abandoned CA2151961A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4242946A DE4242946A1 (de) 1992-12-18 1992-12-18 Neue acyclische Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DEP4242946.3 1992-12-18

Publications (1)

Publication Number Publication Date
CA2151961A1 true CA2151961A1 (fr) 1994-07-07

Family

ID=6475756

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002151961A Abandoned CA2151961A1 (fr) 1992-12-18 1993-12-06 Peptides acycliques analogues du peptide natriuretique atrial; methode de preparation et utilisation

Country Status (6)

Country Link
EP (1) EP0674655A1 (fr)
JP (1) JPH08508465A (fr)
AU (1) AU5697094A (fr)
CA (1) CA2151961A1 (fr)
DE (1) DE4242946A1 (fr)
WO (1) WO1994014840A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061631A1 (fr) * 1999-04-12 2000-10-19 Astrazeneca Ab Antagonistes de pentapeptides modifies du recepteur de la clairance des peptides natriuretiques auriculaires

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970009887B1 (ko) * 1987-12-24 1997-06-19 존 에이취. 뉴만 심방의 나트륨이뇨성 펩티드의 선형유사체
EP0465097A3 (en) * 1990-06-26 1993-03-24 Merck & Co. Inc. Peptides having atrial natriuretic factor activity

Also Published As

Publication number Publication date
DE4242946A1 (de) 1994-06-23
WO1994014840A1 (fr) 1994-07-07
JPH08508465A (ja) 1996-09-10
AU5697094A (en) 1994-07-19
EP0674655A1 (fr) 1995-10-04

Similar Documents

Publication Publication Date Title
KR101441444B1 (ko) 인슐린 유도체
AU764553B2 (en) Inhibitors of alpha 4 beta 1 mediated cell adhesion
AU2008341661B2 (en) An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof
CA2410662C (fr) Nouveau peptide sous forme d'inhibiteurs de protease a serine ns3 d'hepatite virale c
ES2548259T3 (es) Análogo del péptido similar al glucagón-1 y uso del mismo
KR20010022405A (ko) Ｖｌａ-4에 의해 매개된 백혈구 유착을 억제하는설포닐화된 디펩타이드 화합물
US5190922A (en) Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
US7511051B2 (en) Cidofovir peptide conjugates as prodrugs
EP0187622A2 (fr) Dérivés de somatostatine
KR20090025196A (ko) 사이클릭 나트륨 이뇨 펩타이드 구조물
US20020169133A1 (en) Peptidic procollagen C-proteinase inhibitors
JPH06501950A (ja) 環状ペプチド、その調製法およびその薬理組成物としての使用
AU744425B2 (en) 20(s) camptothecin glycoconjugates
AU1907292A (en) Alpha-substituted polypeptides having therapeutic activity
CA2151961A1 (fr) Peptides acycliques analogues du peptide natriuretique atrial; methode de preparation et utilisation
JPS5831337B2 (ja) アンジオテンシン２類似体及びその製法
KR101843248B1 (ko) 흉선 기질 림프단백질 매개 신호전달을 제어하는 펩타이드 유도체 및 이를 포함하는 알러지 및 천식 질환 예방 및 치료용 약학 조성물
CA2151959A1 (fr) Peptides acycliques, sulfures, analogues du peptide natriuretique atrial
JPS60231697A (ja) ペプチド
US4133805A (en) Cyclic undecapeptides related to somatostatin and intermediates therefor
CA2018458A1 (fr) Peptides inhibant le renine
CN113150068B (zh) 一种肽类化合物、其应用及含其的组合物
JPH04244091A (ja) ホスホノピロリジン−およびピペリジン−含有スタチン型偽ペプチド類、それらの製造方法、およびレトロウイルスに対する薬剤としてのそれらの使用
EP0900566A1 (fr) Nouveaux composes de tripeptides et medicaments anti-sida
EA029392B1 (ru) Агонисты рецептора вазопрессина-2

Legal Events

Date Code Title Description
FZDE Dead